Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Spot gold fell nearly $20 in the short term, hitting a new intraday low at $3,979.09 per ounce, down about 0.7%. The decline was driven by persistently high expectations of Federal Reserve rate hikes and a rebound in the US dollar index, which is currently up 0.13% to around 101.30.

Spot gold fell nearly $20 in the short term, hitting a new intraday low at $3,979.09 per ounce, down about 0.7%. The decline was driven by persistently high expectations of Federal Reserve rate hikes and a rebound in the US dollar index, which is currently up 0.13% to around 101.30.

汇通财经汇通财经2026/07/01 01:16
Show original
Spot gold fell nearly $20 in the short term, hitting a new intraday low of $3,979.09 per ounce, a decline of about 0.7%. This is due to persistent expectations of Federal Reserve interest rate hikes and a rebound in the US Dollar Index. The US Dollar Index is currently up 0.13% to around 101.30.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Survival Nearly Doubles! BioNTech (BNTX.US) Lung Cancer Candidate Drug PRESERVE-003 Achieves Success in Late-Stage Trial, Providing Critical Support for Oncology Transformation

BioNTech (BNTX.US) announced on Monday that a late-stage clinical trial demonstrated its candidate drug gotistobart provided a clinically meaningful overall survival benefit compared to standard therapy in a specific type of lung cancer.

智通财经2026/09/14 10:46
Survival Nearly Doubles! BioNTech (BNTX.US) Lung Cancer Candidate Drug PRESERVE-003 Achieves Success in Late-Stage Trial, Providing Critical Support for Oncology Transformation